| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/08/2008 | US7355019 Cysteine-containing peptide tag for site-specific conjugation of proteins |
| 04/08/2008 | US7354947 Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof a JNK inhibitors and compositions and methods related thereto |
| 04/08/2008 | US7354941 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes |
| 04/08/2008 | US7354939 Pyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto |
| 04/08/2008 | US7354934 N1-(1H-Benzimidazol-2-ylmethyl)-N1-(5,6,7,8-tetrahydro-quinolin-8-yl)-butane-1,4-diamine; fusin and chemokine receptor antagonist; increase progenitor and stem cells in humans; HIV, antiinflammatory agent: rheumatoid arthritis, inflammatory bowel disease |
| 04/08/2008 | US7354919 Isoxazole compositions useful as inhibitors of ERK |
| 04/08/2008 | US7354917 Oxabispidine compounds and their use in the treatment of cardiac arrhythmias |
| 04/08/2008 | US7354905 Thrombosis therapy; anticoagulants |
| 04/08/2008 | US7354769 Comparing the ability of N,N-bis(3-D-gluconamidopropyl)-deoxycholamine to inhibit binding of IGFBP-1 or -3 to IGF-1 with the ability of a candidate indirect agonist of IGF-1 to identify effective agonists |
| 04/08/2008 | US7354765 Soybean plants with enhanced expression of daidzein and genistein; for use in improving nutrient quality of foods |
| 04/08/2008 | US7354738 isolated polypeptide modulates activity of nuclear receptor/ nuclear respiratory factor, brown adipose cell determination/differentiation, mitochondrial activity, biogenesis, fatty acid oxidation |
| 04/08/2008 | US7354736 Intracellular caspase inhibitory polypeptide for use in treatment and prevention of cell proliferative, nervous system and autoimmune disorders |
| 04/08/2008 | US7354728 Coactivation of nuclear receptors |
| 04/08/2008 | US7354724 Drosophila G protein coupled receptors, nucleic acids, and methods related to the same |
| 04/08/2008 | US7354585 Methods of treating coagulapathic or thrombotic disorders |
| 04/08/2008 | CA2384739C Plastic films, especially for use in a dermal or transdermal therapeutic system |
| 04/08/2008 | CA2372962C Novel interleukin-1 and tumor necrosis factor-.alpha. modulators, syntheses of said modulators and methods of using said modulators |
| 04/08/2008 | CA2232663C At1-receptor antagonists for preventing and treating postischemic renal failure and for protecting ischemic kidneys |
| 04/08/2008 | CA2187541C Benzoxazepine derivatives, salts thereof, and drugs containing the same |
| 04/08/2008 | CA2141953C Pharmaceutical formulations of interleukin-1 inhibitors |
| 04/03/2008 | WO2008040027A2 Directed differentiation and maturation of stem cell-derived cardiomyocytes |
| 04/03/2008 | WO2008040002A2 Methods, compositions and articles of manufacture for hif modulating compounds |
| 04/03/2008 | WO2008040000A2 Soluble epoxide hydrolase inhibitors |
| 04/03/2008 | WO2008039999A1 Soluble epoxide hydrolase inhibitors |
| 04/03/2008 | WO2008039909A1 Genetic modification of targeted regions of the cardiac conduction system |
| 04/03/2008 | WO2008039139A1 Novel 5,7-disubstituted [1, 3] thiazolo [4, 5] pyrimidin-2 (3h)-amine derivatives and their use in therapy |
| 04/03/2008 | WO2008039138A1 Novel 5, 7-disubstituted [1, 3 ] thiazolo [4, 5-d] pyrimidin-2 (3h)-one derivatives and their use in therapy |
| 04/03/2008 | WO2008039085A1 Triphenylphosphonium thionitrite nitric oxide donors |
| 04/03/2008 | WO2008038849A1 Pharmaceutical composition comprising an extract from opuntia ficus-indica |
| 04/03/2008 | WO2008038771A1 Glutamine-containing composition for increasing blood flow |
| 04/03/2008 | WO2008038768A1 Compound having bicyclic pyrimidine structure and pharmaceutical composition comprising the compound |
| 04/03/2008 | WO2008038705A1 Glycation inhibitor |
| 04/03/2008 | WO2008038692A1 Diaryl ketimine derivative |
| 04/03/2008 | WO2008038587A1 Cd20-negatively converted b cell malignant lymphocyte cell line and utilization of the same |
| 04/03/2008 | WO2008038417A1 Cardiovascular preparation |
| 04/03/2008 | WO2008038394A1 Musclin receptor and use thereof |
| 04/03/2008 | WO2008037922A1 Derivatives of 5-thioxylopyranose and use of same for treatment |
| 04/03/2008 | WO2008037459A1 Pyrazolo [1, 5-a] pyrimidine derivatives and their therapeutic use |
| 04/03/2008 | WO2008037381A1 Substituted 2-phenyl-benzimidazoles and their use as pharmaceuticals |
| 04/03/2008 | WO2008037182A1 Use of ginsenoside rg1 for treatment of cerebral ischemia and/or diseases or symptoms induced by cerebral ischemia |
| 04/03/2008 | WO2007145909A3 Methods and compositions for treating post-myocardial infarction damage |
| 04/03/2008 | WO2007139413A3 Polymorphs of (r) -5- (2-aminoethyl) -1- (6, 8-difluorochroman-3-yl) -1,3- dihydroimidazole-thione hydrochloride |
| 04/03/2008 | WO2007112052A3 Formulations and methods for vascular permeability-related diseases or conditions |
| 04/03/2008 | WO2007070359A3 Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof |
| 04/03/2008 | US20080081825 5-((2,4-difluorophenyl) {[(1-methyl-4-piperidinyl)oxy]imino}methyl)-1-(2,6-dimethylphenyl)-2(1H)-pyridinone; p38 MAP kinase and tumor necrosis factor inhibitor; inflammatory cytokines or chemokine, respiratory diseases, cardiovascular diseases and bone diseases |
| 04/03/2008 | US20080081822 N-(5-tert-Butyl-isoxazol-3-yl)-2-cyclohexanesulfonyl-2-methyl-propionamide; cannabinoid receptor agonist, antagonist; analgesic, antiinflammatory and antitumor agent; neuropatic pain |
| 04/03/2008 | US20080081813 Lipid Lowering Biphenylcarboxamides |
| 04/03/2008 | US20080081793 Oligonucleotide Compositions and Their Use to Induce Apoptosis |
| 04/03/2008 | US20080081081 Complement inhibitors; gene expression inhibition of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecular-1 (VCAM-1), and the production of nitric oxide (NO) |
| 04/03/2008 | US20080081072 Resin-complex granulation for water-soluble drugs and associated methods |
| 04/03/2008 | US20080081066 Reducing blood pressure byorally administering a mixture of L-theanine and a tea polyphenol such as epigallocatechol gallate; antiinflammatory and hypotensive agents; reducing low density lipoproteins |
| 04/03/2008 | CA2665907A1 Derivatives of 5-thioxylopyranose and use of same for treatment |
| 04/03/2008 | CA2664930A1 Novel 5,7-disubstituted[1,3]thiazolo[4,5-d]pyrimidin-2(3h)-amine derivatives and their use in therapy |
| 04/03/2008 | CA2664789A1 5,7-disubstituted[1,3]thiazolo[4,5-d]pyrimidin-2(3h)-one derivatives for the selective inhibtion of chemokine receptors |
| 04/03/2008 | CA2664744A1 Triphenylphosphonium thionitrite nitric oxide donors |
| 04/03/2008 | CA2664375A1 Pyrazolo [1, 5-a] pyrimidine derivatives and their therapeutic use |
| 04/03/2008 | CA2664365A1 Soluble epoxide hydrolase inhibitors |
| 04/03/2008 | CA2664364A1 Soluble epoxide hydrolase inhibitors |
| 04/03/2008 | CA2664358A1 Diarylketimine derivative |
| 04/02/2008 | EP1905830A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 04/02/2008 | EP1905782A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 04/02/2008 | EP1905779A1 Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same |
| 04/02/2008 | EP1905771A2 Quinuclidine derivatives and their use |
| 04/02/2008 | EP1905764A1 Substituted 2-Phenyl-benzimidazoles and their use as pharmaceuticals |
| 04/02/2008 | EP1905763A1 N-acylic aminoacid derivatives. method for the production thereof, pharmacological composition and the use in the form of anti-allergic, anti-inflammatory and hypolipidemic agents |
| 04/02/2008 | EP1905457A1 Angiogenesis and vascular permeability modulators and inhibitors |
| 04/02/2008 | EP1905449A2 Vaccines |
| 04/02/2008 | EP1905444A1 Medicinal composition containing ginseng secondary glycosides, its preparation method and application |
| 04/02/2008 | EP1905441A2 Non-sedating barbiturate compounds as neuroprotective agents |
| 04/02/2008 | EP1905438A2 Hypoglycemic agent |
| 04/02/2008 | EP1905431A1 Pravastatin pharmaceutical formulations and methods of their use |
| 04/02/2008 | EP1904488A1 Pyrazole compounds and thrombopoietin receptor activators |
| 04/02/2008 | EP1904477A1 Indol-3-carbonyl-spiro-piperidine derivatives as v1a receptor antagonists |
| 04/02/2008 | EP1904476A1 Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals |
| 04/02/2008 | EP1904180A2 Pharmaceutical dosage form containing an active principle combination of nifedipine and/or nisoldipine and of an angiotensin ii antagonist |
| 04/02/2008 | EP1904055A1 Composition for inhibiting acyl-coa:cholesterol acyltransferase |
| 04/02/2008 | EP1904050A2 Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to reduce cardiomyopathy |
| 04/02/2008 | EP1903895A2 Calcium-peptide component |
| 04/02/2008 | EP1802581B1 4 [(2,4-dichloro-5-methoxyphenyl)amino]-6-alkoxy-7-ethynyl-3-quinolinecarbonitriles for the treatment of ischemic injury |
| 04/02/2008 | EP1274729B1 G protein coupled receptor |
| 04/02/2008 | EP0964692B1 Use of glp-1 or analogs in treatment of myocardial infarction |
| 04/02/2008 | CN101155916A Targeted plasminogen activator fusion proteins as thrombolytic agents |
| 04/02/2008 | CN101155797A 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors |
| 04/02/2008 | CN101153310A Method for producing anti-hypertension peptide with complex zymohydrolysis of hairtail backbone |
| 04/02/2008 | CN101153055A Novel peptide with angiotonin transferase restraining liveness and method of producing the same |
| 04/02/2008 | CN101153022A Isoquinolinium compound, producing method and application of its salt |
| 04/02/2008 | CN101153021A Isoquinolinium compound, producing method and application of its salt |
| 04/02/2008 | CN101152569A Pharmaceutical composition having preventing, protecting and treating functions for myocardial ischemia and oxygen deficiency type damnification |
| 04/02/2008 | CN101152561A Application of Lefty protein in restraining fibrosis lesion of organ |
| 04/02/2008 | CN101152545A Turmeric water-solubility saponin liposome, preparing method and uses the same |
| 04/02/2008 | CN101152523A Traditional Chinese medicine for treating tremor cordis from deficiency of both qi and yin |
| 04/02/2008 | CN101152519A Traditional Chinese medicine for treating gestational hypertension complex |
| 04/02/2008 | CN101152458A Traditional Chinese medicine preparation for treating cerebral apoplexy sequela |
| 04/02/2008 | CN101152455A Medicine for external application for treating hemiparalysis |
| 04/02/2008 | CN101152454A Chinese medicinal materials for treating dizziness |
| 04/02/2008 | CN101152406A Externally applied medicine for treating varicosity and phlebitis |
| 04/02/2008 | CN101152398A Traditional Chinese medicine for treating hemorrhoid hemorrhage |
| 04/02/2008 | CN101152355A Application of ampelopsis extract in preparing medicament for treating hypertension |
| 04/02/2008 | CN101152341A Health care tea of ganoderma lucidum medicinal herbs |
| 04/02/2008 | CN101152338A Anti-hypertension spray agent |